Critical Limb Ischemia: Is there a role for drug eluting stents in the periphery?

Minneapolis Heart Institute Foundation Cardiology Grand Rounds

Minneapolis Heart Institute Foundation Cardiology Grand Rounds

28:24

In our second installment of the Small Business Starter Kit series - we’re tackling a topic that’s sometimes tricky, sometimes confusing, but ever-present: taxes. Hosts Austin and Jannese have an insightful conversation with entrepreneur Isabella Rosal who started 7th Sky Ventures , an exporter and distributor of craft spirits, beer, and wine. Having lived and worked in two different countries and started a company in a heavily-regulated field, Isabella is no stranger to navigating the paperwork-laden and jargon-infused maze of properly understanding taxes for a newly formed small business. Join us as she shares her story and provides valuable insight into how to tackle your business’ taxes - so they don’t tackle you. Learn more about how QuickBooks can help you grow your business: QuickBooks.com See omnystudio.com/listener for privacy information.…

13 years ago

MP3•Episode home

Dr. Steve Levin, Vascular Fellow at the University of Minnesota, defines critical limb ischemia, identifies the evolving role of drug eluting stents in the treatment of peripheral arterial disease and compares how drug eluting stents have performed relative to balloon angioplasty and bare metal stenting in patients suffering from critical limb ischemia.

12 episodes

Critical Limb Ischemia: Is there a role for drug eluting stents in the periphery?

Minneapolis Heart Institute Foundation Cardiology Grand Rounds

28 subscribers

published 13 years ago

MP3•Episode home

12 episodes

All episodes

Minneapolis Heart Institute Foundation Cardiology Grand Rounds

1
Riata ICD Leads: Is there a problem or just a cosmetic issue?

13 years ago

—

Dr. Raed H. Abdelhadi , Cardiac Electrophysiologist at the Minneapolis Heart Institute at Abbott Northwestern Hospital , reviews the background for the Riata ICD recall and the available data on the Riata ICD lead, explains the preliminary results for the Riata Multicenter Study, discusses the challenges regarding screening and management and summarizes the Riata Summit.…

Minneapolis Heart Institute Foundation Cardiology Grand Rounds

1
Decongestive Strategies in Acute Heart Failure

13 years ago

—

Dr. Steven R. Goldsmith , Professor of Medicine at the University of Minnesota , Director of the Heart Failure Program at Hennepin County Medical Center , and Director of the Minnesota Heart Failure Consortium , explains the importance of congestion as a contributor to the pathophysiology of acute heart failure, describes the limits of current decongestive strategies and the promise of newer modalities and discusses emerging insights concerning the relationship between congestion and the cardiorenal syndrom in acute heart failure.…

Minneapolis Heart Institute Foundation Cardiology Grand Rounds

1
Atrial Fibrillation: New Agents for Stroke Prevention

13 years ago

—

Dr. R. Jeffrey Westcott , Medical Director at the Cardiac Cath Lab at the Swedish Heart and Vascular Institute , discusses the pharmacology of the new oral direct thrombin and Xa inhibitors, evaluates what patients are more likely to experience bleeding complications and discusses the advantages of these agents versus warfarin in treating patients with non-valvular atrial fibrillation.…

Minneapolis Heart Institute Foundation Cardiology Grand Rounds

1
TCT/AHA Highlights: Platelets and Stem Cells

13 years ago

—

Dr. Timothy Henry , Director of Research at the Minneapolis Heart Institute Foundation , and Dr. Jay Traverse , Senior Consulting Cardiologist at the Minneapolis Heart Institute at Abbott Northwestern Hospital , review the results of the LateTIME, SCIPIO and CADUCEUS trials.

Minneapolis Heart Institute Foundation Cardiology Grand Rounds

1
Update in Preventive Cardiology 2011

13 years ago

—

Dr. Thomas Knickelbine , Director of Preventive Cardiology at the Minneapolis Heart Institute at Abbott Northwestern Hospital discusses US population risk factors, explains how to approach patients with statin intolerance, describes the current approaches to treatment of non-HDL cholesterol and Metabolic Syndrome and outlines MHI prevention goals and future vision.…

Minneapolis Heart Institute Foundation Cardiology Grand Rounds

1
AHA Abstract Presentations

13 years ago

—

Acute Aortic Intramural Hematoma: an analysis from the International Registry of Acute Aortic Dissection - Presented by Dr. Kevin M. Harris Circadian Dependence of Infarct Size and Left-Ventricular Function Following ST-Elevation Myocardial Infarction - Presented by Dr. Ronald Reiter Cardiogenic Shock in Cardiac Arrest No Longer a Contraindication for Therapeutic Hypothermia - Presented by Fourth-Year Medical Student, Kalie Y. Kebed Prevalence of Premature Coronary Heart Disease and Female Gender in Patients Presenting with ST-Elevation Myocardial Infarction - Presented by Dr. Michael D. Miedema…

Minneapolis Heart Institute Foundation Cardiology Grand Rounds

1
Critical Limb Ischemia: Is there a role for drug eluting stents in the periphery?

13 years ago

—

Dr. Steve Levin , Vascular Fellow at the University of Minnesota , defines critical limb ischemia, identifies the evolving role of drug eluting stents in the treatment of peripheral arterial disease and compares how drug eluting stents have performed relative to balloon angioplasty and bare metal stenting in patients suffering from critical limb ischemia.…

Minneapolis Heart Institute Foundation Cardiology Grand Rounds

1
Repairing Valves: Why and Why Not?

13 years ago

—

Dr. Benjamin Sun , Chair of Cardiac, Thoracic and Transplant Surgery at the Minneapolis Heart Institute at Abbott Northwestern Hospital , identifies which valves can be repaired, explains why we don't repair valves more frequently and describes when valve replacement is still preferred.

Minneapolis Heart Institute Foundation Cardiology Grand Rounds

1
Cardiac Resynchronization Therapy: Developing a Center of Excellence

13 years ago

—

Dr. Alan J. Bank , Medical Director of Research at United Heart and Vascular Clinic , and Associate Professor of Cardiology at the University of Minnesota , describes the components of a CRT Center of Excellence, explains the mechanisms of action of CRT, discusses the importance of mechanical dyssynchrony in heart failure, and describes the effects of CRT in patients with NYHA Class II heart failure.…

Minneapolis Heart Institute Foundation Cardiology Grand Rounds

1
A Serious Complication of a Common Vascular Practice

13 years ago

—

Dr. Nedaa Skeik , Vascular Medicine Consultant at the Minneapolis Heart Institute® at Abbott Northwestern Hospital , explains different treatment modalities for deep vein thrombosis (DVT), describes the history of inferior vena cava (IVC) filters, lists indications and complications (common and rare) of IVC filters, and explains identification and management of arterial pseudoaneurysm as a rare complication of IVC filters.…

Minneapolis Heart Institute Foundation Cardiology Grand Rounds

1
Sudden Death, Risk Stratification and Prevention in Hypertrophic Cardiomyopathy

14 years ago

—

Dr. Barry J. Maron , Director of the Hypertrophic Cardiomyopathy Center at the Minneapolis Heart Institute at Abbott-Northwestern Hospital looks explains how to risk stratify hypertrophic cardiomyopathy (HCM) patients and describes the role of the implantable cardioverter defibrillator in HCM patients.…

Minneapolis Heart Institute Foundation Cardiology Grand Rounds

1
Pacing the Heart: What side are you on?

14 years ago